{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:50:45Z","timestamp":1792180245677,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101492","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:39:48Z","timestamp":1747251588000},"page":"101492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors"],"prefix":"10.1016","volume":"33","author":[{"given":"Chlo\u00e9","family":"Fustinoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Patr\u00edcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101492_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101309","article-title":"Characterization of AAV vectors: A review of analytical techniques and critical quality attributes","volume":"32","author":"Kontogiannis","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.omtm.2021.02.010","article-title":"Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies","volume":"20","author":"Gimpel","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101132","article-title":"PCR-based analytics of gene therapies using adeno-associated virus vectors: Considerations for cGMP method development","volume":"31","author":"Blay","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2022.830421","article-title":"Process improvement of adeno-associated virus (AAV) production","volume":"4","author":"Guan","year":"2022","journal-title":"Front. Chem. Eng."},{"key":"10.1016\/j.omtm.2025.101492_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101230","article-title":"Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1020174","article-title":"AAV process intensification by perfusion bioreaction and integrated clarification","volume":"10","author":"Mendes","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101492_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101266","article-title":"Adeno-associated virus perfusion enhanced expression: A commercially scalable, high titer, high quality producer cell line process","volume":"32","author":"Xue","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.omtm.2021.04.006","article-title":"Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells","volume":"21","author":"Nguyen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400526","article-title":"Towards a Platform Chromatography Purification Process for Adeno-Associated Virus (AAV)","volume":"20","author":"Bogdanovic","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtm.2025.101492_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ymthe.2004.08.030","article-title":"Herpesvirus-based infectious tittering of recombinant adeno-associated viral vectors","volume":"11","author":"Mohiuddin","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.omtm.2025.101492_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the Center of the Cell: Tracing the Path of AAV Transduction","volume":"27","author":"Dhungel","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2025.101492_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/gt.2010.27","article-title":"Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors","volume":"17","author":"Zeltner","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.omtm.2018.07.004","article-title":"Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls","volume":"27","author":"Fran\u00e7ois","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/hum.2023.014","article-title":"Improvement of precision in recombinant adeno-associated virus infectious titer assay with droplet digital PCR as an endpoint measurement","volume":"34","author":"Duong","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/1043034041361262","article-title":"Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious events","volume":"15","author":"Zen","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib18","first-page":"1124","article-title":"A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors","volume":"3","author":"Clark","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib19","article-title":"Sensitive Determination of Infectious Titer of Recombinant Adeno-Associated Viruses (rAAVs) Using TCID50 End-Point Dilution and Quantitative Polymerase Chain Reaction (qPCR)","volume":"1","author":"Lock","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.omtm.2025.101492_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/hum.2014.057","article-title":"Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material","volume":"25","author":"Ayuso","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101492_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41467-022-28738-2","article-title":"Self-attenuated adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination","volume":"13","author":"Su","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101492_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48901-z","article-title":"AAV production in stable packaging cells requires expression of adenovirus 22\/33K protein to allow episomal amplification of integrated rep\/cap genes","volume":"13","author":"Su","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101492_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101320","article-title":"Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform","volume":"32","author":"Roach","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib24","first-page":"192","article-title":"Gene Editing of Primary Rhesus Macaque B Cells","volume":"10","author":"Hartweger","year":"2023","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtm.2025.101492_bib25","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"Jogler","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101492_bib26","first-page":"3073","article-title":"Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo","volume":"63","author":"Zhao","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2025.101492_bib27","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1073\/pnas.96.6.2615","article-title":"Site-specific integration mediated by a hybrid adenovirus\/adeno-associated virus vector","volume":"96","author":"Recchia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101492_bib28","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1093\/nar\/gkt172","article-title":"The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells","volume":"41","author":"Kamel","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2025.101492_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtm.2021.05.003","article-title":"Development of a one-step RT-ddPCR method to determine the expression and potency of AAV vectors","volume":"23","author":"Clarner","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101492_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-genom-083115-022536","article-title":"Lessons from HeLa Cells: The Ethics and Policy of Biospecimens","volume":"17","author":"Beskow","year":"2016","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101492_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-422X-10-74","article-title":"A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype","volume":"10","author":"Ellis","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.omtm.2025.101492_bib32","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1128\/jvi.71.9.6816-6822.1997","article-title":"Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production","volume":"71","author":"Allen","year":"1997","journal-title":"J. Virol."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:54:01Z","timestamp":1759863241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000877"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101492","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101492"}}